Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance

Y Liu, H Lei, W Zhang, Q Xing, R Liu, S Wu, Z Liu… - Cell Death & …, 2023 - nature.com
Pyroptosis is a novel inflammatory form of regulated cell death (RCD), characterized by cell
swelling, membrane rupture, and pro-inflammatory effects. It is recognized as a potent …

[HTML][HTML] New progress in drugs treatment of diabetic kidney disease

J Wang, H Xiang, Y Lu, T Wu, G Ji - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Diabetic kidney disease (DKD) is not only one of the main complications of diabetes, but
also the leading cause of the end-stage renal disease (ESRD). The occurrence and …

Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19

A Saeedi-Boroujeni… - …, 2021 - Taylor & Francis
SARS-CoV-2 is a type of beta-CoV that develops acute pneumonia, which is an
inflammatory condition. A cytokine storm has been recognized as one of the leading causes …

The mechanism and regulation of the NLRP3 inflammasome during fibrosis

CM Artlett - Biomolecules, 2022 - mdpi.com
Fibrosis is often the end result of chronic inflammation. It is characterized by the excessive
deposition of extracellular matrix. This leads to structural alterations in the tissue, causing …

Protein lysine acetylation played an important role in NH3-induced AEC2 damage and pulmonary fibrosis in piglets

X Wang, D Zhang, Y Zhu, D Li, L Shen, Q Wang… - Science of The Total …, 2024 - Elsevier
Abstract Gaseous ammonia (NH 3), as a main air pollutant in pig farms and surrounding
areas, directly affects animal and human health. The lung, as an important organ for gas …

Tranilast inhibits angiotensin II-induced myocardial fibrosis through S100A11/transforming growth factor-β (TGF-β1)/Smad axis

Y Chen, M Huang, Y Yan, D He - Bioengineered, 2021 - Taylor & Francis
Tranilast has an ameliorative effect on myocardial fibrosis (MF), but the specific mechanism
has not been studied. S100A11 is a key regulator of collagen expression in MF. In this …

New therapeutic approaches against pulmonary fibrosis

D Yu, Y Xiang, T Gou, R Tong, C Xu, L Chen… - Bioorganic …, 2023 - Elsevier
Pulmonary fibrosis is the end-stage change of a large class of lung diseases characterized
by the proliferation of fibroblasts and the accumulation of a large amount of extracellular …

[HTML][HTML] Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis

HV Charan, DK Dwivedi, S Khan, G Jena - Genes & Diseases, 2023 - Elsevier
The liver injury leads to an inflammatory response, which causes the activation of hepatic
stellate cells (HSCs) that further secrete ECM proteins and play an important role in liver …

The tumor microenvironment: shaping cancer progression and treatment response

SA Desai, VP Patel, KP Bhosle, SD Nagare… - Journal of …, 2023 - Taylor & Francis
The tumor microenvironment (TME) plays a crucial role in cancer progression and treatment
response. It comprises a complex network of stromal cells, immune cells, extracellular …

IPF-fibroblast Erk1/2 activity is independent from microRNA cluster 17-92 but can be inhibited by treprostinil through DUSP1

S Blumer, L Fang, WC Chen, P Khan, K Hostettler… - Cells, 2021 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a progressive terminal lung disease, and therapies aim
to block fibrosis. Fibroblast proliferation is controlled by C/EBP-β, microRNA cluster 17-92 …